RXO Inc (RXO) Price

RXO's 32% Rebound Tested by BofA Forecast Cut and S&P Downgrade

RXO's valuation is under scrutiny after BofA Securities cut its fourth-quarter EBITDA forecast and S&P Global Ratings shifted its outlook to negative, even as the stock posted a 32% gain over the last 30 days.